Medevol meets key stakeholders at BioConnect Ireland
Medevol Limited attended the excellent BioConnect Ireland network meeting in early June in Dublin which was entitled “Phase to Phase with Ireland’s Clinical Trial Potential”. The message is clear if we are to compete on a global stage we must ensure we have the infrastructure in place to support a streamlined set up to ensure we are afforded the best chance to recruit patients within competitive timeframes…..
BioConnect Ireland was founded to promote forward-thinking interaction and exchange between all the stakeholders in academia, industry, government agencies, trade, professional services and financial organizations that are involved in biotechnology, life science and medical devices in Ireland, North and South. Ann Hever from the Irish Health Research Board outlined their plan to develop a coherent health research system. The potential to increase the number of clinical trials being conducted in Ireland is clear when you compare the number of open clinical trials in Ireland with like sized Nordic countries where we see up to 5 times the number of trials being conducted.